15 Nov, 2022
Hempire Technology Group has been granted a patent for cannabinoid composition and its application in the preparation of medicine for the treatment of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
This is another breakthrough after Group been granted relevant patent in China and Hong Kong.
At present, the Group is cooperating with Japan's top scientific research institutions and universities to carry out research and development of new medicines based on relevant patents, striving to fully verify the safety and effectiveness and looking forward to marketing in Japan.
